|
Number
|
168
|
155
| |
|
Gender female, n (%)
|
75 (44.6)
|
69 (44.5)
|
0.98
|
|
Age in years, median (Q1–Q3)
|
67.9 (56.4–74.7)
|
67.3 (58–74.5)
|
0.98
|
|
Type of patients, n (%)
| | |
0.58
|
|
Medical
|
139 (82.7)
|
127 (82)
| |
|
Surgical
|
24 (14.3)
|
20 (12.9)
| |
|
Trauma
|
5 (3)
|
8 (5.2)
| |
|
Reason for admission, n (%)
| | |
0.13
|
|
Neuro
|
39 (24.7)
|
21 (14.7)
| |
|
Cardiac
|
21 (13.3)
|
29 (20.3)
| |
|
Respiratory
|
53 (33.5)
|
46 (32.2)
| |
|
Digestive
|
18 (11.4)
|
25 (17.5)
| |
|
Kidney
|
2 (1.3)
|
5 (3.5)
| |
|
Sepsis
|
15 (9.5)
|
10 (7)
| |
|
Other
|
10 (6.3)
|
7 (4.9)
| |
|
Charlson score, median (Q1–Q3)
|
2 (1–4)
|
2 (1–4)
|
0.77
|
|
SAPS II, median (Q1–Q3)
|
48 (38–60)
|
48 (40–62)
|
0.85
|
|
SOFA 1st day, median (Q1–Q3)
|
8 (6–10)
|
8 (6–11)
|
0.06
|
|
Antibiotic therapy on intubation, n (%)
|
119 (70.8)
|
121 (78.1)
|
0.14
|
|
Reason, n (%)
| | |
0.048
|
|
Central nervous system infection
|
3 (1.8)
|
3 (1.9)
| |
|
Respiratory infection
|
79 (47)
|
60 (38.7)
| |
|
Intra-abdominal infection
|
5 (3)
|
17 (11)
| |
|
Urinary tract infection
|
6 (3.6)
|
7 (4.5)
| |
|
Sepsis
|
14 (8.3)
|
13 (8.4)
| |
|
Soft tissue infection
|
3 (1.8)
|
2 (1.3)
| |
|
Prophylaxis
|
4 (2.4)
|
6 (3.9)
| |
|
Other
|
5 (3)
|
13 (8.4)
| |
|
Type of antibiotic therapy given on intubation, n (%)
| | |
0.10
|
|
None
|
53 (31.6)
|
35 (22.6)
| |
|
Amoxycillin–clavulanic acid
|
25 (21)
|
27 (22.3)
| |
|
Third generation cephalosporin
|
16 (13.5)
|
29 (24)
| |
|
Large spectrum antibioticsa
|
62 (52.1)
|
54 (44.6)
| |
|
Otherb
|
12 (10.1)
|
10 (8.3)
| |
